IMP4

gene
On this page

Also known as MGC19606BXDC4

Summary

IMP4 (IMP U3 small nucleolar ribonucleoprotein 4, HGNC:30856) is a protein-coding gene on chromosome 2q21.1, encoding U3 small nucleolar ribonucleoprotein protein IMP4 (Q96G21). Component of the 60-80S U3 small nucleolar ribonucleoprotein (U3 snoRNP). It is a common-essential gene (DepMap: required in 99.4% of cancer cell lines).

The protein encoded by this gene, along with IMP3 and MPP10, is part of the 60-80S U3 small nucleolar ribonucleoprotein (U3 snoRNP) complex. This complex is necessary for the early cleavage steps of pre-18S ribosomal RNA processing. Several transcript variants encoding different isoforms have been found for this gene.

Source: NCBI Gene 92856 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 72 total
  • Cancer dependency (DepMap): dependent in 99.4% of screened cell lines (common-essential)
  • MANE Select transcript: NM_033416

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:30856
Approved symbolIMP4
NameIMP U3 small nucleolar ribonucleoprotein 4
Location2q21.1
Locus typegene with protein product
StatusApproved
AliasesMGC19606, BXDC4
Ensembl geneENSG00000136718
Ensembl biotypeprotein_coding
OMIM612981
Entrez92856

Gene structure

Transcript identifiers

Ensembl transcripts: 24 — 12 protein_coding, 11 retained_intron, 1 nonsense_mediated_decay

ENST00000259239, ENST00000409649, ENST00000409935, ENST00000428740, ENST00000452955, ENST00000456713, ENST00000460100, ENST00000460766, ENST00000462357, ENST00000462392, ENST00000464432, ENST00000470672, ENST00000473689, ENST00000475074, ENST00000477375, ENST00000490895, ENST00000495606, ENST00000859438, ENST00000859439, ENST00000859440, ENST00000859441, ENST00000927812, ENST00000951188, ENST00000951189

RefSeq mRNA: 16 — MANE Select: NM_033416 NM_001320304, NM_001320305, NM_001320306, NM_001320307, NM_001320309, NM_001320310, NM_001320311, NM_001371725, NM_001371726, NM_001371728, NM_001371730, NM_001371731, NM_001371732, NM_001371733, NM_001371734, NM_033416

CCDS: CCDS2160

Canonical transcript exons

ENST00000259239 — 9 exons

ExonStartEnd
ENSE00001070705130346356130347967
ENSE00001813756130342897130342935
ENSE00003520818130343086130343194
ENSE00003529709130345567130345699
ENSE00003553218130346201130346274
ENSE00003635872130346018130346112
ENSE00003640369130345779130345933
ENSE00003657765130344629130344712
ENSE00003692975130345376130345485

Expression profiles

Bgee: expression breadth ubiquitous, 286 present calls, max score 97.28.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 50.5899 / max 274.1558, expressed in 1825 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
2250150.58991825

Top tissues by expression

298 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
body of pancreasUBERON:000115097.28gold quality
gastrocnemiusUBERON:000138896.42gold quality
muscle of legUBERON:000138395.97gold quality
body of stomachUBERON:000116195.70gold quality
lower esophagus muscularis layerUBERON:003583395.49gold quality
lower esophagusUBERON:001347395.48gold quality
right lobe of liverUBERON:000111495.41gold quality
hindlimb stylopod muscleUBERON:000425295.39gold quality
mucosa of transverse colonUBERON:000499195.36gold quality
left coronary arteryUBERON:000162695.31gold quality
prefrontal cortexUBERON:000045195.19gold quality
granulocyteCL:000009495.18gold quality
apex of heartUBERON:000209895.16gold quality
triceps brachiiUBERON:000150995.15gold quality
heart left ventricleUBERON:000208495.13gold quality
coronary arteryUBERON:000162194.99gold quality
cardiac ventricleUBERON:000208294.95gold quality
esophagogastric junction muscularis propriaUBERON:003584194.95gold quality
right coronary arteryUBERON:000162594.91gold quality
muscle organUBERON:000163094.91gold quality
skeletal muscle organUBERON:001489294.91gold quality
right atrium auricular regionUBERON:000663194.86gold quality
popliteal arteryUBERON:000225094.70gold quality
tibial arteryUBERON:000761094.69gold quality
left adrenal glandUBERON:000123494.66gold quality
omental fat padUBERON:001041494.66gold quality
peritoneumUBERON:000235894.64gold quality
left adrenal gland cortexUBERON:003582594.64gold quality
muscle layer of sigmoid colonUBERON:003580594.56gold quality
right adrenal glandUBERON:000123394.55gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-MTAB-6379no721.53
E-MTAB-7249no223.68
E-ANND-3no0.00

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

51 targeting IMP4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-7110-3P100.0073.182486
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-4481100.0066.421669
HSA-MIR-6873-3P100.0071.422626
HSA-MIR-453199.9969.703181
HSA-MIR-186-5P99.9970.833707
HSA-MIR-4745-5P99.9865.951028
HSA-MIR-3688-3P99.9772.022834
HSA-MIR-3065-5P99.9771.563281
HSA-MIR-6888-3P99.9765.951170
HSA-MIR-314899.9775.066478
HSA-MIR-450B-5P99.9271.483175
HSA-MIR-3529-3P99.9073.553045
HSA-MIR-684499.8270.692423
HSA-MIR-6817-3P99.7968.352126
HSA-MIR-453099.6966.471509
HSA-MIR-466399.6265.33957
HSA-MIR-451699.6167.783390
HSA-MIR-205399.5769.151635
HSA-MIR-141-5P99.5767.86897
HSA-MIR-143-3P99.4969.051457
HSA-MIR-477099.4969.091451
HSA-MIR-103A-1-5P99.3967.781545
HSA-MIR-103A-2-5P99.3967.721577
HSA-MIR-4796-5P99.3470.06810
HSA-MIR-608899.2968.451284
HSA-MIR-196A-3P99.1967.341204
HSA-MIR-505-3P99.1969.71896
HSA-MIR-140-3P99.0467.691324
HSA-MIR-480198.9669.422096

Functional genomics

DepMap (CRISPR cell-line fitness): dependent in 99.4% of screened cell lines, common-essential.

Literature-anchored findings (GeneRIF, showing 1)

  • DDX10 promotes human lung carcinoma proliferation by U3 small nucleolar ribonucleoprotein IMP4. (PMID:33973712)

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
danio_rerioimp4ENSDARG00000054540
mus_musculusImp4ENSMUSG00000026127
rattus_norvegicusImp4ENSRNOG00000013285
drosophila_melanogasterCG11920FBGN0039274
caenorhabditis_elegansWBGENE00014083

Paralogs (1): RPF1 (ENSG00000117133)

Protein

Protein identifiers

U3 small nucleolar ribonucleoprotein protein IMP4Q96G21 (reviewed: Q96G21)

Alternative names: Brix domain-containing protein 4

All UniProt accessions (6): B8ZZ47, B9A008, Q96G21, E7ENR5, F8WCN0, H0Y714

UniProt curated annotations — full annotation on UniProt →

Function. Component of the 60-80S U3 small nucleolar ribonucleoprotein (U3 snoRNP). Required for the early cleavages during pre-18S ribosomal RNA processing. Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding, modifications, rearrangements and cleavage as well as targeted degradation of pre-ribosomal RNA by the RNA exosome.

Subunit / interactions. Part of the small subunit (SSU) processome, composed of more than 70 proteins and the RNA chaperone small nucleolar RNA (snoRNA) U3. Component of a heterotrimeric complex containing IMP3, IMP4 and MPHOSPH10. Interacts with MPHOSPH10.

Subcellular location. Nucleus. Nucleolus.

RefSeq proteins (16): NP_001307233, NP_001307234, NP_001307235, NP_001307236, NP_001307238, NP_001307239, NP_001307240, NP_001358654, NP_001358655, NP_001358657, NP_001358659, NP_001358660, NP_001358661, NP_001358662, NP_001358663, NP_219484* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR007109BrixDomain
IPR044281IMP4/RPF1Family

Pfam: PF04427

UniProt features (2 total): chain 1, domain 1

Structure

Experimental structures (PDB)

3 structures.

PDBMethodResolution (Å)
7MQAELECTRON MICROSCOPY2.7
7MQ8ELECTRON MICROSCOPY3.6
7MQ9ELECTRON MICROSCOPY3.87

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q96G21-F189.470.57

Function

Pathways and Gene Ontology

Reactome pathways

5 pathways

IDPathway
R-HSA-6790901rRNA modification in the nucleus and cytosol
R-HSA-6791226Major pathway of rRNA processing in the nucleolus and cytosol
R-HSA-72312rRNA processing
R-HSA-8868773rRNA processing in the nucleus and cytosol
R-HSA-8953854Metabolism of RNA

MSigDB gene sets: 151 (showing top): GSE45365_NK_CELL_VS_BCELL_DN, GOBP_RIBOSOME_BIOGENESIS, SHEPARD_CRASH_AND_BURN_MUTANT_UP, GOBP_MATURATION_OF_SSU_RRNA, ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN, WEI_MYCN_TARGETS_WITH_E_BOX, GOBP_RIBOSOMAL_SMALL_SUBUNIT_BIOGENESIS, GOBP_RIBONUCLEOPROTEIN_COMPLEX_BIOGENESIS, TAANNYSGCG_UNKNOWN, REACTOME_METABOLISM_OF_RNA, GOCC_90S_PRERIBOSOME, GOCC_PRERIBOSOME, GOCC_SMALL_SUBUNIT_PROCESSOME, GOCC_NUCLEOLUS, BLALOCK_ALZHEIMERS_DISEASE_DN

GO Biological Process (4): rRNA processing (GO:0006364), maturation of SSU-rRNA (GO:0030490), ribosomal small subunit biogenesis (GO:0042274), ribosome biogenesis (GO:0042254)

GO Molecular Function (4): snoRNA binding (GO:0030515), rRNA primary transcript binding (GO:0042134), protein binding (GO:0005515), rRNA binding (GO:0019843)

GO Cellular Component (8): fibrillar center (GO:0001650), nucleoplasm (GO:0005654), nucleolus (GO:0005730), preribosome (GO:0030684), small-subunit processome (GO:0032040), Mpp10 complex (GO:0034457), nucleus (GO:0005634), ribonucleoprotein complex (GO:1990904)

Reactome top-level categories

Rollup of top-3 pathways:

CategoryPathways
rRNA processing in the nucleus and cytosol2
Metabolism of RNA1
rRNA processing1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
nucleolus3
ribosome biogenesis2
ribonucleoprotein complex biogenesis2
RNA binding2
cellular anatomical structure2
nuclear lumen2
nuclear protein-containing complex2
RNA processing1
rRNA metabolic process1
rRNA processing1
ribosomal small subunit biogenesis1
rRNA binding1
binding1
intracellular membraneless organelle1
ribonucleoprotein complex1
preribosome1
t-UTP complex1
90S preribosome1
intracellular membrane-bounded organelle1
protein-containing complex1

Protein interactions and networks

STRING

1998 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
IMP4MRPL2Q5T653576
IMP4MRPS12O15235544
IMP4MRPL17Q9NRX2480
IMP4DDX28Q9NUL7447
IMP4MRPL11Q9Y3B7446
IMP4CSDC2Q9Y534400
IMP4ORC1Q13415393
IMP4MXRA8Q9BRK3365
IMP4ACAT2Q9BWD1357
IMP4RPF2Q9H7B2353
IMP4GNL2Q13823352
IMP4IMP3Q9NV31352
IMP4ZFPL1O95159351
IMP4BRIX1Q8TDN6351
IMP4NIP7Q9Y221350

IntAct

121 interactions, top by confidence:

ABTypeScore
CFTRESYT2psi-mi:“MI:2364”(proximity)0.710
ZBTB7BIMP4psi-mi:“MI:0915”(physical association)0.670
IMP4ZBTB7Bpsi-mi:“MI:0915”(physical association)0.670
IMP3MPHOSPH10psi-mi:“MI:0914”(association)0.670
NOP53RRP8psi-mi:“MI:0914”(association)0.640
ZBTB7BIMP4psi-mi:“MI:0915”(physical association)0.560
IMP4MPHOSPH10psi-mi:“MI:0915”(physical association)0.560
RBM34NVLpsi-mi:“MI:0914”(association)0.530
ILF2IGF2BP3psi-mi:“MI:0914”(association)0.530
RPL37AMPHOSPH10psi-mi:“MI:0914”(association)0.530
ZNF2MPHOSPH10psi-mi:“MI:0914”(association)0.530
RPL30RRP8psi-mi:“MI:0914”(association)0.530
RPL18ARRP8psi-mi:“MI:0914”(association)0.530
NRBM47psi-mi:“MI:0914”(association)0.530
RPS3ZNF316psi-mi:“MI:0914”(association)0.530
MAGEB2GTPBP10psi-mi:“MI:0914”(association)0.530
KRR1MPHOSPH10psi-mi:“MI:0914”(association)0.530
IMP4psi-mi:“MI:0915”(physical association)0.400
IMP4LTB4R2psi-mi:“MI:0915”(physical association)0.370
RRP1BZNF785psi-mi:“MI:0914”(association)0.350
Prdm16ESYT2psi-mi:“MI:0914”(association)0.350

BioGRID (139): IMP4 (Two-hybrid), IMP4 (Affinity Capture-MS), IMP4 (Co-fractionation), IMP4 (Co-fractionation), IMP4 (Co-fractionation), NAT10 (Co-fractionation), NOL10 (Co-fractionation), IMP4 (Reconstituted Complex), IMP4 (Affinity Capture-MS), IMP4 (Two-hybrid), IMP4 (Two-hybrid), IMP4 (Affinity Capture-MS), IMP4 (Affinity Capture-MS), IMP4 (Affinity Capture-MS), IMP4 (Affinity Capture-MS)

ESM2 similar proteins: G0S488, G0S616, G0SF80, O13823, O14180, O14206, O62518, P12531, P30190, P34524, P36160, P38789, P38805, P53941, P54073, Q01879, Q08235, Q09817, Q0VD01, Q12153, Q196X4, Q54DJ0, Q54JN0, Q54N44, Q5PQR5, Q5R631, Q5R947, Q5RJS9, Q6BYD9, Q6C804, Q6FNN7, Q6IQU6, Q755T8, Q7S302, Q7TND5, Q8AVP1, Q8VHZ7, Q96G21, Q96X45, Q9ASU7

Diamond homologs: O13823, O14180, O62518, P53941, P54073, Q0VD01, Q5PQR5, Q5R631, Q5R947, Q5RJS9, Q6BYD9, Q6C804, Q6FNN7, Q6IQU6, Q755T8, Q7TND5, Q8AVP1, Q8VHZ7, Q96G21, Q9H9Y2, Q9VKB4, Q9YC08, P38805, Q975H1, Q5JDM5, O26776, O74104, Q467K0, Q58012, Q6M0M3, Q8TQ11, Q8TZI2, Q9UXB9, Q9V200

SIGNOR signaling

1 interactions.

AEffectBMechanism
MPHOSPH10“up-regulates activity”IMP4binding

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 110 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Peptide chain elongation1935.5×2e-23
Viral mRNA Translation1935.5×2e-23
PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA1935.1×2e-23
Selenocysteine synthesis1933.6×4e-23
Eukaryotic Translation Termination1933.6×4e-23
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)1932.9×4e-23
ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA1932.9×4e-23
Formation of a pool of free 40S subunits1931.3×1e-22

GO biological processes:

GO termPartnersFoldFDR
cytoplasmic translation2139.7×8e-26
ribosomal large subunit biogenesis731.7×2e-07
rRNA processing1724.6×3e-17
ribosomal small subunit biogenesis1023.2×2e-09
translation2021.0×7e-19
regulation of alternative mRNA splicing, via spliceosome614.9×2e-04
negative regulation of translation612.0×7e-04
RNA processing511.2×3e-03

Disease & clinical

Clinical variants and AI predictions

ClinVar

72 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance61
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

0 predictions. Top by Δscore:

AlphaMissense

1866 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
2:130345793:A:CS152R0.998
2:130345795:C:AS152R0.998
2:130345795:C:GS152R0.998
2:130345796:C:GH153D0.998
2:130345818:C:AA160D0.998
2:130346103:T:AI227K0.998
2:130345459:A:CS94R0.997
2:130345461:T:AS94R0.997
2:130345461:T:GS94R0.997
2:130345644:C:GC128W0.997
2:130345809:G:AG157D0.997
2:130345643:G:AC128Y0.996
2:130345667:T:CL136P0.996
2:130345791:T:AV151D0.996
2:130346103:T:GI227R0.996
2:130346112:G:CR230P0.996
2:130345402:T:CY75H0.995
2:130345469:T:AL97H0.995
2:130345642:T:CC128R0.995
2:130345808:G:CG157R0.995
2:130345890:C:AP184H0.995
2:130345926:G:AG196D0.995
2:130346253:G:AG248R0.995
2:130346253:G:CG248R0.995
2:130346254:G:AG248E0.995
2:130346365:T:AI258N0.995
2:130345478:T:CF100S0.994
2:130345567:G:AE103K0.994
2:130345571:T:CL104P0.994
2:130345605:C:AN115K0.994

dbSNP variants (sampled 300 via entrez): RS1000095126 (2:130341416 C>T), RS1000327396 (2:130344162 A>T), RS1000490505 (2:130342695 A>C,G), RS1001074332 (2:130347813 C>T), RS1001333652 (2:130347597 C>A), RS1001713789 (2:130345496 G>T), RS1001756408 (2:130345041 C>G), RS1002322825 (2:130341306 G>C), RS1003066533 (2:130342516 G>T), RS1003265265 (2:130343879 G>T), RS1003386114 (2:130344150 A>G), RS1003677034 (2:130341995 T>A,C), RS1003938501 (2:130344485 C>A,T), RS1004940446 (2:130345807 T>C), RS1005205304 (2:130343522 G>A)

Disease associations

OMIM: gene MIM:612981 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

28 total (human), top 28 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidincreases expression, affects cotreatment5
sodium arsenitedecreases expression, affects cotreatment, increases abundance, increases expression2
bisphenol Aaffects expression1
beta-lapachoneincreases expression1
manganese chlorideaffects cotreatment, increases abundance, increases expression1
di-n-butylphosphoric acidaffects expression1
2-palmitoylglycerolincreases expression1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideaffects cotreatment, increases expression1
abrineincreases expression1
dorsomorphinincreases expression, affects cotreatment1
jinfukangaffects cotreatment, decreases expression1
Sunitinibincreases expression1
Arsenicaffects cotreatment, increases abundance, increases expression1
Cisplatinaffects cotreatment, decreases expression1
Coumestrolincreases expression1
Estradiolincreases expression1
Ethyl Methanesulfonatedecreases expression1
Formaldehydedecreases expression1
Manganeseaffects cotreatment, increases abundance, increases expression1
Methyl Methanesulfonatedecreases expression1
Plant Extractsdecreases expression1
Ribonucleotidesaffects binding1
Silicon Dioxideincreases expression1
T-2 Toxinincreases expression1
Thiramdecreases expression1
Tobacco Smoke Pollutionincreases expression1
Tretinoindecreases expression1
Cyclosporineincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.